Workflow
ABACHEM(300261)
icon
Search documents
雅本化学(300261) - 2024年年度股东大会决议公告
2025-05-13 10:30
证券代码:300261 证券简称:雅本化学 公告编号:2025-045 雅本化学股份有限公司 2024 年年度股东大会决议公告 特别提示: 1、本次股东大会无增加、变更、否决议案的情况。 2、本次股东大会以现场投票和网络投票相结合的方式召开。 一、会议召开和出席情况 雅本化学股份有限公司(以下简称"公司")2024 年年度股东大会(以下 简称"股东大会")现场会议于 2025 年 5 月 13 日下午 14:30 在上海市浦东新区 李冰路 67 弄 4 号雅本张江创新中心召开;同时使用深圳证券交易所交易系统网 络投票于 2025 年 5 月 13 日交易时间接受网络投票,即 9:15-9:25,9:30-11:30 和 13:00-15:00;使用深圳证券交易所互联网投票系统于 2025 年 5 月 13 日上午 9:15 至下午 15:00 期间接受网络投票。 出席本次股东大会的股东及股东的委托代理人共计 302 人,代表有表决权的 股份数为 275,251,895 股,占公司股份总数的 28.5736%。其中,参加现场会议的 股东及股东代表 4 人,代表股份 265,398,089 股,占公司股份总数的 ...
雅本化学(300261) - 雅本化学2024年年度股东大会的法律意见书
2025-05-13 10:30
中国上海市石门一路 288 号 电子邮件 E-mail: email@fangdalaw.com 兴业太古汇香港兴业中心二座 24 楼 电 话 Tel.: +86-21-2208 1166 邮政编码:200041 传 真 Fax.: +86-21-5298 5599 24/F, HKRI Centre Two HKRI Taikoo Hui 288 Shi Men Yi Road Shanghai, PRC 200041 上海市方达律师事务所 关于雅本化学股份有限公司 2024 年年度股东大会的 法律意见书 FANGDA PARTNERS http://www.fangdalaw.com 致:雅本化学股份有限公司 上海市方达律师事务所(以下简称"本所")是具有中华人民共和国境内法 律执业资格的律师事务所。根据相关法律顾问协议,本所指派律师出席雅本化学 股份有限公司(以下简称"公司")2024 年年度股东大会(以下简称"本次股东 大会"),并就本次股东大会的召集和召开程序、参与表决和召集会议人员的资格、 表决程序和表决结果等有关事宜出具本法律意见书。 本法律意见书依据《中华人民共和国公司法》《中华人民共和国证券 ...
研判2025!中国绝缘制品行业相关政策、产业链图谱、发展现状、重点企业分析及未来展望:绝缘制品市场规模持续增长,行业向绿色化方向发展[图]
Chan Ye Xin Xi Wang· 2025-05-12 01:23
Industry Overview - The insulation products industry in China has developed rapidly since the 1990s, establishing a comprehensive industrial system and becoming the largest insulation products market globally. The market size is projected to reach approximately 77.5 billion yuan in 2024, with a year-on-year growth of 2.79% [1][14]. - The industry has matured technologically, with leading companies capable of developing high-end insulation products, gaining competitive advantages in international markets [1][14]. Market Dynamics - The insulation products are essential components in electrical equipment and electronic devices, serving various functions such as mechanical support, heat dissipation, and moisture protection [3]. - The industry benefits from the rapid development of sectors like renewable energy, efficient energy-saving motors, and rail transportation, contributing to a relatively prosperous market environment [5]. Policy Environment - Recent policies have been introduced to support the insulation products industry, including the "Implementation Plan for Accelerating the Breakthrough of 'Six New' Manufacturing in Henan Province" and the "Implementation Plan for the Innovation and Development of the Fine Chemical Industry (2024-2027)" [5][7]. Industry Chain - The upstream of the insulation products industry includes raw materials such as phenol, formaldehyde, and epoxy resin, which are essential for production. The industry is moving towards high-quality and environmentally friendly production due to supply-side structural reforms [8][10]. - The downstream applications include generator manufacturing, power transmission, new energy vehicles, and electronic communications, with increasing demand driven by the national "dual carbon" goals [8][11]. Key Companies - Notable companies in the insulation products sector include Dongcai Technology, Huazheng New Materials, and Shunma Electric, among others. These companies are focusing on innovation and expanding their market presence [16][19][21]. - Dongcai Technology reported a revenue of 32.45 million yuan in the first quarter of 2024, while Huazheng New Materials achieved 28.24 million yuan in the same period [18]. Development Trends - The industry is expected to focus on technological innovation, particularly in high-performance and environmentally friendly insulation materials. Innovations such as nano-modification and composite insulation technologies are anticipated to gain traction [23][24]. - The shift towards green and sustainable practices is becoming a priority, with increasing demand for halogen-free and biodegradable insulation materials [24][25]. Conclusion - The insulation products industry in China is poised for growth, driven by technological advancements, supportive policies, and expanding applications across various sectors. The competitive landscape is evolving, with both international giants and domestic players striving for market share through innovation and quality improvements [16][23].
雅本化学2025年一季度盈利能力回升但现金流和债务状况需关注
Zheng Quan Zhi Xing· 2025-04-27 02:02
Core Viewpoint - Yabon's Q1 2025 report indicates a recovery in profitability despite ongoing net losses, highlighting improvements in revenue and cost management [1][2][7] Financial Overview - Total revenue for Q1 2025 reached 316 million yuan, a year-on-year increase of 43.52% [2] - The net profit attributable to shareholders was -12.76 million yuan, but this represents a 72.01% improvement year-on-year [2] - The non-recurring net profit was also negative at -14.29 million yuan, showing a 64.76% year-on-year increase [2] Profitability - The gross margin improved to 20.81%, reflecting a year-on-year increase of 25.74% [3] - The net margin was -4.94%, which is a 75.47% improvement compared to the previous year [3] Costs and Expenses - Total selling, administrative, and financial expenses amounted to 47.33 million yuan, accounting for 14.99% of revenue, a decrease of 44.69% year-on-year [4] Cash Flow and Asset Status - Operating cash flow per share was -0.04 yuan, a significant decrease of 675.75% year-on-year [5] - Monetary funds totaled 257 million yuan, down 25.80% from the previous year [5] - Accounts receivable increased to 527 million yuan, a year-on-year rise of 3.09% [5] Debt Situation - Interest-bearing liabilities stood at 1.159 billion yuan, a slight decrease of 0.16% year-on-year [6] - The interest-bearing asset-liability ratio was 29.37%, with interest-bearing liabilities being 13.59 times the average operating cash flow over the past three years, indicating some pressure in debt management [6] Summary - Overall, Yabon has shown signs of profitability recovery in Q1 2025, but attention is needed on cash flow and debt management to ensure long-term stability [7]
雅本化学:2025一季报净利润-0.13亿 同比增长71.74%
Tong Hua Shun Cai Bao· 2025-04-25 08:33
Financial Performance - The company reported a basic earnings per share of -0.0134 yuan for Q1 2025, an improvement of 71.79% compared to -0.0475 yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 3.16 billion yuan, representing a 43.64% increase from 2.2 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.13 billion yuan, showing a 71.74% improvement from -0.46 billion yuan in Q1 2024 [1] - The return on equity (ROE) for Q1 2025 was -0.64%, a significant improvement of 68.16% from -2.01% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 39,118.42 million shares, accounting for 41.75% of the circulating shares, with a decrease of 682.77 million shares compared to the previous period [1] - Ningbo Yaben Holdings Co., Ltd. remains the largest shareholder with 25,772.98 million shares, representing 27.50% of the total share capital, unchanged from the previous period [2] - Zhang Yuxin reduced his holdings by 200,000 shares, now holding 2,290,000 shares, which is 2.44% of the total [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [2]
雅本化学(300261) - 2025 Q1 - 季度财报
2025-04-25 08:20
Financial Performance - The company's revenue for Q1 2025 was ¥315,662,234.29, representing a 43.52% increase compared to ¥219,942,064.63 in the same period last year[5]. - The net loss attributable to shareholders decreased to ¥12,756,486.98, a 72.01% improvement from a loss of ¥45,576,667.50 in the previous year[5]. - Basic and diluted earnings per share improved to ¥-0.0134, up 71.79% from ¥-0.0475 in the previous year[5]. - The company reported a net loss of ¥15,589,530.61, compared to a net loss of ¥44,286,323.71 in the previous period, indicating an improvement in financial performance[26]. - Total comprehensive income for the period was ¥-21,356,799.10, compared to ¥-57,137,857.45 in the previous period, showing a reduction in overall losses[26]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥-36,521,335.71, a significant decline of 675.75% compared to a positive cash flow of ¥6,343,271.16 in the same period last year[5]. - Operating cash flow generated a net outflow of ¥36,521,335.71, a significant decline from a net inflow of ¥6,343,271.16 in the previous period, highlighting cash flow challenges[28]. - The company's cash and cash equivalents decreased to CNY 257,153,760.78 from CNY 375,698,283.35, reflecting a decline of approximately 31.5%[20]. - The company's total liabilities increased, with cash and cash equivalents at the end of the period standing at ¥233,300,287.85, down from ¥314,720,829.76[28]. Assets and Liabilities - Total assets at the end of Q1 2025 were ¥3,945,983,317.97, a decrease of 1.82% from ¥4,019,170,670.70 at the end of the previous year[5]. - Total liabilities decreased to CNY 1,819,377,387.22 from CNY 1,875,453,209.03, indicating a decline of about 3.0%[22]. - The company's equity attributable to shareholders decreased to CNY 1,991,413,951.39 from CNY 2,006,889,890.10, reflecting a decrease of approximately 0.8%[22]. - The total operating costs for the current period amount to CNY 330,163,793.31, up from CNY 264,464,096.65 in the previous period, indicating an increase of about 24.8%[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 61,488[13]. - The largest shareholder, Ningbo Yaben Holdings Co., Ltd., holds 26.75% of shares, totaling 257,729,839 shares[13]. - The second-largest shareholder, Wang Xinya, holds 6.75% of shares, totaling 65,000,350 shares[13]. - The company has a total of 3,624,450 restricted shares at the end of the reporting period, with 906,113 shares added during the period[15]. - The company has signed a concerted action agreement among certain shareholders, maintaining relationships among some parties[14]. Research and Development - Research and development expenses increased by 51.96% to ¥29,449,161.26, up from ¥19,379,345.49 in the same period last year, indicating a focus on innovation[10]. - Research and development expenses increased to ¥29,449,161.26 from ¥19,379,345.49, reflecting a focus on innovation and new product development[25]. Financial Management - The company reported a significant increase in other income, which rose by 123.49% to ¥1,821,395.79, primarily due to government subsidies related to digital transformation[10]. - The company's financial expenses decreased by 86.98% to ¥1,344,753.10, largely due to the impact of exchange rate gains[10]. - The company incurred financial expenses of ¥1,344,753.10, a decrease from ¥10,328,357.64, indicating improved cost management[25]. - The company experienced a 34.42% increase in contract liabilities, reaching ¥11,308,308.10, primarily due to an increase in advance payments received[10]. Changes in Control and Governance - The actual controller of the company has changed, with the new controllers being Cai Tong and Wang Xinya, following the exit of Wang Zhuoying and Ma Lifan from the joint action agreement[18]. - The company continues to maintain its controlling shareholder, Ningbo Yaben Holdings Co., Ltd., despite the change in actual controllers[18]. - The company plans to hold a board election for the sixth board of directors, with terms lasting three years from the date of approval[17].
雅本化学(300261) - 关于控股股东部分股份质押展期的公告
2025-04-24 08:18
本公司及董事会全体成员保证公告内容真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏。 雅本化学股份有限公司(以下简称"公司")近日接到控股股东宁波雅本控 股有限公司(以下简称"宁波雅本")的通知,宁波雅本将其持有的部分公司股 份办理了股份质押展期业务,具体事项如下: 二、股东股份累计质押的情况 截至本公告日,上述股东及其一致行动人所持质押股份情况如下: 证券代码:300261 证券简称:雅本化学 公告编号:2025-043 雅本化学股份有限公司 关于控股股东部分股份质押展期的公告 股东 名称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押 数量 (股) 占其 所持 股份 比例 (%) 占公 司总 股本 比例 (%) 是否 为限 售股 是否 为补 充质 押 质押起 始日 质押到 期日 展期 后到 期日 质权人 质押 用途 宁波 雅本 控股 有限 公司 是 6,880,000 2.67 0.71 否 否 2024 年 4 月 22 日 2025 年 4 月 22 日 2026 年4月 22 日 东吴证 券股份 有限公 司 融资 合计 - 6,880,000 2.67 0.71 - - - - ...
雅本化学第二份ESG报告出炉,探索绿色增长、包容共赢的高质量发展路径
Core Viewpoint - Yabon's commitment to sustainable development in the agrochemical industry is highlighted through its 2024 annual and ESG reports, emphasizing the integration of ESG principles into its business strategy and operations [1] Group 1: ESG Commitment and Strategy - Yabon Chemical's second ESG report reflects its ongoing efforts to enhance ESG management and align with regulatory requirements, aiming to provide robust support for sustainable development [1] - The chairman emphasizes that ESG is a core competitive advantage and a responsibility, advocating for a green, innovative, and talent-driven approach to long-term success [1] Group 2: Environmental Management and Pollution Control - The company has established a comprehensive environmental management system focusing on pollution prevention, monitoring, and emergency response, achieving ISO14001 certification for its main production bases [2][3] - Yabon has implemented strict pollution control measures, resulting in zero environmental pollution incidents during the reporting period, with all pollutant emissions meeting regulatory standards [3] Group 3: Biodiversity and Product Innovation - Yabon actively participates in global biodiversity initiatives, developing seven low-ecological-impact agrochemical products to minimize harm to non-target species and ecosystems [3] - The company's innovative fluorouracil product reduces pesticide usage and protects pollinators, demonstrating a commitment to balancing business growth with environmental protection [3] Group 4: Technological Innovation and Low-Carbon Transition - Yabon has increased its investment in green innovation, allocating 123 million yuan for R&D in 2024, and has established a collaborative innovation network across four R&D centers [4] - The company’s subsidiary, Aierwang, contributes to carbon reduction efforts, achieving an annual reduction of approximately 3 million tons of carbon emissions through unique waste treatment technologies [4] Group 5: Employee Welfare and Safety - Yabon has developed a diverse workplace ecosystem, employing 1,180 individuals, including foreign and minority employees, and has implemented measures to protect employee rights, particularly for women [6] - The company has invested over 10 million yuan in safety training and has enhanced its safety management systems, significantly improving workplace safety and operational stability [7] Group 6: Financial Performance and Shareholder Returns - In a challenging macroeconomic environment, Yabon has distributed 48.1655 million yuan in dividends, reflecting its commitment to balancing sustainable development with shareholder returns [7]
雅本化学2024年报解读:聚焦主业稳根基,研发创新蓄势未来
Quan Jing Wang· 2025-04-23 03:03
4月23日,雅本化学(300261)股份有限公司(股票代码:300261)正式发布2024年年度报告。尽管受行 业周期波动及市场竞争加剧影响,公司业绩短期承压,但通过深化主业布局、强化研发投入及优化管理 结构,雅本化学在核心业务领域展现出较强的韧性,为未来高质量发展奠定了坚实基础。 报告期内,雅本化学实现营业收入12.02亿元,同比下降6.00%;归属于上市公司股东的净利润为-2.58亿 元,亏损同比扩大。这一表现主要受农药行业景气度下行、产品价格波动及市场竞争等因素影响。 然而,细分业务数据显示,公司核心主业仍保持稳定增长:农药中间体业务收入6.81亿元,同比增长 2.06%;医药中间体业务收入3.33亿元,同比增长1.10%。 公司坚持"大客户战略",与跨国农化巨头及创新药企建立深度合作,形成了"核心客户+重点产品"的业 务矩阵。南通基地、兰州基地等生产基地的产能爬坡及新项目落地,进一步巩固了公司在定制生产 (CDMO)领域的市场地位。此外,盐城基地作为唯一具备农药全产业链生产能力的基地,有效提升了供 应链稳定性。 面对行业挑战,雅本化学逆势加大研发投入,技术壁垒持续筑高。2024年研发费用达1.23亿元 ...
雅本化学(300261) - 中国国际金融股份有限公司关于公司2024年度募集资金存放与使用情况的专项核查意见
2025-04-22 14:33
中国国际金融股份有限公司 关于雅本化学股份有限公司 2024 年度募集资金存放与使用情况的专项核查意见 中国国际金融股份有限公司(以下简称"中金公司"或"保荐机构")作为雅本 化学股份有限公司(以下简称"雅本化学"或"公司")2017 年非公开发行股票的保 荐机构,根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票 上市规则》等相关法律、法规和规范性文件的要求,对雅本化学 2024 年度相关 募集资金存放与使用情况进行了审慎核查,具体情况如下: 一、募集资金基本情况 经中国证券监督管理委员会《关于核准雅本化学股份有限公司非公开发行股 票的批复》"证监许可[2017]1091 号"的核准,公司共计向特定对象非公开发行人 民币普通股(A 股)105,231,796 股,共计募集人民币 867,109,999.04 元,扣除发 行费人民币 19,496,012.15 元,募集资金净额为人民币 847,613,986.89 元,其中计 入"股本"人民币 105,231,796.00 元,计入"资本公积-股本溢价"人民币 742,382,190.89 元。 截至 2017 年 12 月 19 日止,上述募集 ...